Research programme: HIV protease inhibitors - Korea Institute of Science and Technology
Alternative Names: HIV protease inhibitors research programme - Korea Institute of Science and TechnologyLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Korea Institute of Science and Technology
- Class
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 24 Aug 2006 No development reported - Preclinical for HIV infections treatment in South Korea (unspecified route)
- 19 Sep 2001 Preclinical development for HIV infections treatment in South Korea (Unknown route)